The Korea Innovative Medicines Consortium (KIMCo) said Monday that it would conduct a joint investment project to help strengthen the Korean biopharmaceutical industry’s global competitiveness.
ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most
